Preferences help
enabled [disable] Abstract
Number of results
2017 | 80 | 116-142
Article title

Efficacy of Rectal Artesunate on Parasitaemia and Febrile Condition of Children of Ogun State, South-Western Nigeria

Title variants
Languages of publication
Efficacy of Rectal Artesunate on parasitaemia and febrile condition of children was assessed in 905 children below the age of 5 years. Grid systematic method was employed in selecting sixteen study centres from 8 Local Government Areas of Ogun State. Ethical approvals were obtained in addition to interactive sessions with parents of the children and PHCs medical practitioners. Body weight and temperature were taken and drug was administered at a dose of 5 to 10mg/kg of the body weight per rectum at 0 hour, 24 hours and 48 hours. Efficacy of treatment was monitored by analysing blood samples taken at 0 hour, 24 hours and 48 hours for Malaria Parasites Count (MPC/µl), parasitized red blood cells (PRBC). Data obtained were analyzed using SPSS version 20 to assess association with p-value of < 0.05. A significant (p < 0.05) difference was observed between malaria parasites prevalence at 0 hour, 24 hours and 48 hours. Also a baseline mean malaria parasite density (MPC/µl) of 3,320/μl was observed at 0 hour and a reduction in mean MPC/µl of 1,230/μl and 420/μl at 24 hours and 48 hours respectively with a significant (p < 0.05) difference between MPC/µl at 0 hour, 24 hours and 48 hours. Baseline mean parasitized red blood cells (PRBC) of 4.2 % was observed at 0 hour with reduction in mean PRBC of 2.4 % and 1.1 % at 24 and 48 hours respectively with a significant (p < 0.05) difference between PRBC at 0 hour, 24 hours and 48 hours. Fever Subsidence Ratio between 0 hour, 24 hours and 48 hours were 1.4:1.1. Rectal artesunate is highly effective and well tolerated antimalarial suppository for pre-referral and parenteral therapy.
Physical description
  • Parasitology Unit, Department of Biological Sc., University of Agriculture, Abeokuta Nigeria
  • Parasitology Unit, Department of Biological Sc., University of Agriculture, Abeokuta Nigeria
  • Parasitology Unit, Department of Biological Sc., University of Agriculture, Abeokuta Nigeria
  • Department of Biochemistry, University of Agriculture, Abeokuta Nigeria
  • Executive Secretary Office, National University Commission, Abuja, Nigeria
  • [1] Aceng, J.R., Byarugaba, J.S. and Tumwine, J.K. 2005. Rectal Artemether versus Intravenous Quinine for the Treatment of Cerebral Malaria in Children in Uganda: Randomized Clinical Trial. British Medical Journal, 330(7487): 334-340.
  • [2] Adesola, A.H. 2012. Challenges of Malaria Control in Peri-Urban Communities of High Endemicity. Research Journal of Environmental and Earth Sciences, 4(9): 844-849.
  • [3] Adu-Gyasi, D., Adams, M., Amoako. S., Mahama, E., Nsoh, M., Amenga-Etego, S.B., Asante, K.P., Newton, S. and Owusu, S. 2012. Estimating Malaria Parasite Density: Assumed White Blood Cell Count of 10,000/µl of Blood is appropriate measure in Central Ghana. Malaria Journal, 11: 238.
  • [4] Agbenyega, T. 2008. Efficacy and safety of rectal Artesunate in paediatric patients -a randomized controlled study (Ghana). TDR Annual Report.
  • [5] Agbolade, J.M., Akintola, O.B., Agu, N.C., Raufu, T. and Johnson, O. 2008. Protection Practices against Mosquito among Students of a Tertiary Institution in Southwest Nigeria. World Applied Sciences Journal, 5(1): 25-28.
  • [6] Ajayi, I.O., Afonne, C., Dada-Adegbola, H. and Falade, C.O. 2015. Prevalence of Asymptomatic Malaria and Intestinal Helminthiasis Co-infection among Children Living in Selected Rural Communities in Ibadan Nigeria. American Journal of Epidemiology and Infectious Disease, 3(1): 15-20.
  • [7] Awad, M.I., Alkadru, A.M.Y., Behrens, R.H., Baraka, O.Z. and Eltayeb, I.B. 2003. Descriptive Study on the Efficacy and Safety of Artesunate Suppository in Combination with other Anti-Malarias in the Treatment of Severe Malaria in Sudan. American Journal of Tropical Medicine and Hygiene. 63: 153-158.
  • [8] Bar-Zeev, N. and White, N.J. 2006. Evidence behind the WHO Guidelines: Hospital Care for Children: Efficacy and Safety of Artemisinin Derivatives in Children with Malaria. Journal of Tropical Pediatrics, 52(2): 78-82.
  • [9] Carter, J.Y. and Lema, O.E. 1993. Practical Laboratory Manual for Health Centers in Eastern African. African Medical and Research Foundation, Nairobi, Kenya. 87-143.
  • [10] Cheesbrough, M. 2009. Parasitological Tests. Part 1: District Laboratory Practice in Tropical Countries, 2nd ed. Cambridge: Cambridge University Press, pp. 178-309.
  • [11] Dada-Adegbola, H.O., Oluwatoba, O.A. and Falade, C.O. 2013. Asymptomatic Malaria and Intestinal Helminth Co-Infection among Children in a Rural Community in Southwest Nigeria. MWJ, 4: 18
  • [12] Dondorp, A., Nosten, F., Stepniewska, K., Day, N. and White N.J. 2005. Artesunate versus Quinine for Treatment of Severe Malaria: A Randomized Trial. Lancet. 366: 717-725.
  • [13] Ekong, U., Oyo-Ita, A., Odey, F., Effa, E., Esu, E., Oduwole, O., Chibuzor, M. and Meremikwu, M. 2013. Management of Uncomplicated Malaria in Under-fives in Private and Public Health Facilities in South-Eastern Nigeria: A Clinical Audit of Current Practices. Malaria Research and Treatment, 6.
  • [14] Erhabor, O., Mohammad, H.J., Ahmed, H.M. andEzimah, A.C.U. 2014. Effect of Plasmodium Parasitaemia on some Haematological Parameters in Children Living in Sokoto, North Western, Nigeria. International Journal of Clinical Medicine Research, 1(2): 57-64.
  • [15] Flegg, J.A., Guérin, P.J., Nosten, F., Ashley, E.A., Phyo, A.P., Dondorp, A.M., Fairhurst, R.M., Socheat, D., Borrmann, S., Björkman, A., Mårtensson, A., Mayxay, M., Newton, P.N., Bethell, D., Se, Y., Noedl, H., Diakite, M., Djimde, A.A., Hien, T.T. White, N. J. and Stepniewska, K. 2013. Optimal Sampling Designs for Estimation of P. falciparum Clearance Rates in Patients Treated with Artemisinin Derivatives. Malaria Journal, 12: 411.
  • [16] Gomes, M., Ribeiro, I., Warsame, M., Karunajeewa, H. and Petzold, M. 2008. Rectal Artemisinins for Malaria: A Review of Efficacy and Safety from Individual Patient Data in Clinical Studies. Bio Medical Central, 8: 39
  • [17] Gomes, M.F., Faiz, M.A. and Gyapong G.O. 2009. Pre-Referral Rectal Artesunate to Prevent Death and Disability in Severe Malaria: A Placebo-Controlled Trial. Lancet, 373: 557-566.
  • [18] Gomez, L.E.A. 1996. Efficacy of Artesunate Suppository Followed by Oral Mefloquine in the Treatment of Severe Falciparum Malaria in Endemic Areas where Resistance to Chloroquine Exists in Ecuador. Japanese Journal of Tropical Medicine and Hygine, 24(suppl 1): 17-24.
  • [19] Grobusch, M. 2009. Early Rectal Artesunate Administration: A Life-Saver in Remote Areas. Ingental connect Future Microbiology, 4: 397-400
  • [20] Hendriksen, I.C., Mtove, G., Kent, A., Gesase, S., Reyburn, H. and Lemnge, M.M. 2013. Population Pharmacokinetics of Intramuscular Artesunate in African Children with Severemalaria: Implications for a Practical Dosing Regimen. Clinical and Pharmacological Theory, 93(5): 443-50.
  • [21] Hinton, R.L., Auwun, A., Pongua, G., Davis, T.M.E, Karunajeewa, H.A. and Reeder, J.C. 2007. Caregivers’ Acceptance of Using Artesunate Suppositories for Treating Childhood Malaria in Papua New Guinea. American Journal of Tropical Medicine and Hygiene, 76: 634-640.
  • [22] Hirji, K.F., and Premji, Z.G. 2011. Pre-Referral Rectal Artesunate in Severe Malaria: Flawed Trial. Trials, 12: 188.
  • [23] Hsu, E. 2010. Qing hao… (Herbal Artemisiae annuae) in the Chinese Materia Medica, in Elisabeth Hsu and Stephen Harris, eds., Plants, Health and Healing: On the Interface of Ethnobotany and Medical Anthropology, Berghahan Books, Oxford and New York, 83-120.
  • [24] Hürlimann, E., Houngbedji, C.A., N’Dri, P.B., Bänninger, D., Coulibaly, J.T., Yap, P., Silué, K.D., N’Goran, E.K., Raso, G. and Utzinger, J. 2014. Effect of Deworming on School-Aged Children’s Physical Fitness, Cognition and Clinical Parameters in a Malaria-Helminth Co-Endemic Area of Côte d’Ivoire. BMC Infectious Diseases, 14: 411.
  • [25] Inthavilay, S., Franchard, T., Meimei, Y., Ashley, E.A. and Barennes, H. 2010. Knowledge and Acceptability of the Rectal Treatment Route in Laos and Its Application for Pre-Referral Emergency Malaria Treatment. Malaria Journal, 9: 342.
  • [26] Jonathan, K.A. and Agbolade O.M. 2012. Plasmodium and Loa Loa Infections among Secondary School Teachers and Students, and Ante-Natal Out-Patients in Ijebu North Area, South-Western Nigeria. International Research Journal of Microbiology 3(7): 253-257.
  • [27] Kaona, F. A. and Tuba, M. 2005. A Qualitative Study to Identify Community Structures for Management of Severe Malaria: A Basis for Introducing Rectal Artesunate in the Under Five Years Children in Nakonde District of Zambia. BMC Public Health, 5(1): 28.
  • [28] Karunajeewa, H.A., Ilett, K.F., Dufall, K., Kemiki, A., Bockarie, M., Alpers, M.P., Barrett, P.H., Vicini, P. and Davis T.M. 2004. Disposition of Artesunate and DihydroArtemisinin after Administration of Artesunate Suppositories in Children from Papua New Guinea with Uncomplicated Malaria. Antimicrobial Agent of Chemotherapy, 48: 2966-2972.
  • [29] Karunajeewa, H.A., Kemiki, A., Alpers, M.P., Lorry, K., Batty, K.T., Ilett, K.F., and Davis T.M. 2003. Safety and Therapeutic Efficacy of Artesunate Suppositories for Treatment of Malaria in Children in Papua New Guinea. Pediatric Infectious Diseases Journal, 22: 251-256.
  • [30] Karunajeewa, H.A., Manninig, L., Mueller, I.., Ilett, K.F. and Davis, T.M.E. 2007. Rectal Administration of Artemisinin Derivatives for the Treatment of Malaria. JAMA, 297: 2381-2390.
  • [31] Karunajeewa, H.A., Reeder, J., Lorry, K., Dabod, E., Hamzah, J., PAge-Sharp, M., Chiswell, G.M., Ilett, K.F. and Davis, T.M. 2006. Artesunate Suppositories versus Intramuscular Artemether for Treatment of Severe Malaria in Children in Papua New Guinea. Antimicrobial Agents Chemotherapy, 50: 968-974.
  • [32] Kassile, T. 2012. Prevention and Management of Malaria in Under-Five Children in Tanzania: A Review. Tanzania Journal of Health Research, 14: 14.
  • [33] Knoblauch, A.M, Mirko, S., Winkler, C.A., Mark, J.D., Milka, O., Raoul, M.Y., Pokou, A.Y. and Jürg, U. 2014. The Epidemiology of Malaria and Anaemia in the Bonikro Mining Area, Central Côte d’Ivoire. Malaria Journal, 13: 194.
  • [34] Kotepui, M., Bhukdee, P., Nuoil, P., Chaowanee, C. and Suwit, D. 2014. Effect of Malarial Infection on Haematological Parameters in Population near Thailand-Myanmar Border. Malaria Journal, 13: 218.
  • [35] Kothari, C.R. 2005. Research Methodology: Methods and Techniques, Second Edition, New Age International Publishers, Washington DC.
  • [36] Krishna, S., Planche, T., Agbenyega, T., Woodrow, C., Agranoff, D., Bedu-Addo, G., Owusu-Ofori, A., Appiah, J., Ramanathan, S., Mansor, S., Navaratnam, V. 2001. Bioavailability and preliminary clinical efficacy of intrarectal Artesunate in Ghanaian children with moderate malaria. Antimicrobial Agents Chemotherapy. 45: 509-516.
  • [37] Meier zu Biesen, C. 2010. The Rise to Prominence of Artemisia annua L.-The Transformation of a Chinese Plant to a Global Pharmaceutical. African Sociological Review, 14(2): 24-46.
  • [38] Miller, L.H. and Su, X. 2011. Artemisinin: Discovery from the Chinese Herbal Garden. Cell, 146: 855-858.
  • [39] Mogaji, H.O., Adeniran, A.A., Awoyale, A.K., Oluwole, A.S. and Ekpo, U.F. 2013. Baseline Study of Malaria Infection in Four Rural Communities of Ogun State. Asian Journal of Biological Science, 6(6): 300-305.
  • [40] Mordi, R.M., and Borke, M.E. 2013. The Prevalence of Malaria in Edo State Nigeria Journal of Microbiology Research, 1(2): 18-23.
  • [41] Morris, C.A., Stephan, D., Borghini-Fuhrer, I., Jung, D., Chang-Sik, S. and Lawrence, F. 2011. Review of the Clinical Pharmacokinetics of Artesunate and Its Active Metabolite Dihydro Artemisinin Following Intravenous, Intramuscular, Oral or Rectal Administration. Malaria Journal, 10: 263.
  • [42] Nwani, P.O., Unekwe, P.C., Oguejiofor, O.C. 2004. The Efficacy of Artesunate Suppositories [Plasmotrim 200 Rectocap (R)] in the Treatment of Adults with Acute Malaria. Journal of Medical Research and Technology, 1(2): 42-49.
  • [43] Okoli, C. A. Okolo, S. N., Collins. J. C. 2013. P. falciparum Infection among Neonates in the North Central Region of Nigeria. Journal of Infectious Diseases of Developing Countries, 7(5): 265-371.
  • [44] Okonko, I.O., Adejuwon, A.O., Okerentungba, P.O. and Frank-Peterside, N. 2012. P. falciparum and HIV- 1/2 Coinfection among Children Presenting at the Out-Patient Clinic of Oni Memorial Children Hospital in Ibadan, Southwestern Nigeria. Nature and Science, 10(8): 94-100.
  • [45] Olasehinde, G., Ajayi, A.A., Taiwo, S.O., Adekeye, B.T. and Adeyeba, O.A. 2010. Prevalence and Management of falciparum Malaria among Infants and Children in Ota, Ogun State, South Western Nigeria. African Journal Clinical Experiment in Microbiology, 11(3): 199-163.
  • [46] Olasunkanmi, O.I., Akingbade, O.A., Akinjinmi, A.A., Okerentugba, P.O., Onajobi, I.B.and Okonko, I.O. 2013. Prevalence of Malaria Plasmodium among Children in Abeokuta, Nigeria. Academic Arena, 5(10): 44-47
  • [47] Rutebemberwa, E., Pariyo, G., Peterson, S., Tomson, G. and Kallander, K. 2009. Utilization of Public or Private Health Care Providers by Febrile Children after User Fee Removal in Uganda. Malaria Journal, 8.
  • [48] Sam-Wobo, S.O. and Asiwaju R.T. 2014. Status of falciparum Malaria in Some Granite Mining Communities of Odeda Local Government Area, Ogun State, Nigeria. Research Journal in Engineering and Applied Sciences, 3(1): 34-37.
  • [49] Sam-Wobo, S.O., Agbeyangi, O.A., Ekpo, U.F. Akinloye, O.A., Mafiana, C.F. and Adeleke, M.A. 2012. Rectal Artesunate, their Utilization and Parental Perception in the Management of Malaria in Children from Abeokuta, South-Western Nigeria. Journal of Vector-Borne and Zoonotic Diseases, 12(2): 151-155.
  • [50] Simba, D.O., Kakoko, D.C., Warsame, M., Premji, Z., Gomes, M.F., Tomson, G. and Johansson E. 2010. Understanding Caretakers’ Dilemma in Deciding Whether or Not to Adhere with Referral Advice after Pre-Referral Treatment with Rectal Artesunate. Malaria Journal, 9: 123.
  • [51] Takem, Ebako, N., Achidi, E.M. and Ndumbe, P.M. 2010. An Update of Malaria Infection and Anaemia in Adults in Buea, Cameroon, BMC Research Notes, 3: 121.
  • [52] TDR, 2008. Efficacy and safety of rectal Artesunate as emergency treatment in children with severe malaria who are unable to take oral medication, and development of appropriate strategies for its use. Annual report.
  • [53] Ukwaja, K.N., Aina, O.B. and Talabi. A. A. 2011. Clinical Overlap Between Malaria and Pneumonia: Can Malaria Rapid Diagnostic Test Play a Role? Journal of Infection of Developing Countries, 5(3): 199-203.
  • [54] Warsame, M., Kimbute, O., Machinda, Z., Ruddy, P., Melkisedick, M., Peto, T., Ribeiro, I., Kitua, A., Tomson, G. and Gomes, M. 2007. Recognition, Perceptions and Treatment Practices for Severe Malaria in Rural Tanzania: Implications for Accessing Rectal Artesunate as a Pre-Referral. Plos One, 2: e149.
  • [55] World Health Organization. 2001a. Tropical Disease Research, Progress 1999-2000. Special Programme for Research and Training in Tropical Diseases, 15th programme report. TDR/GEN/01.5.
  • [56] World Health Organization. 2007. Artemisinin-Based Suppositories in the Management of Severe Malaria (Rectal Artemisinin). Report of an Informal Consultation, Global malaria Programme, Geneva. WHO/H.T.M/MAL, 1118: 1-16.
  • [57] World Health Organization. 2010. Basic Malaria Microscopy. Part 1. Learner’s Guide. 2nd ed. Geneva: WHO; 2010.
  • [58] World Health Organization. 2012. WHO handbook for guideline development.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.